HEMOSENSE, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • March 31st, 2005 • Hemosense Inc • Delaware
This Indemnification Agreement (“Agreement”) is made as of this day of , , by and between HemoSense, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
SUPPLY AND LICENSE AGREEMENTSupply and License Agreement • March 31st, 2005 • Hemosense Inc • Massachusetts
This Supply and License Agreement (“Agreement”) is made and entered into this 5th day of March, 1999, by and between Dade Behring Inc., (“Dade Behring”) a Delaware corporation with a principal place of business at 1717 Deerfield Road, Deerfield, Illinois 60015 and HemoSense, Inc., a Delaware corporation (“HemoSense”) having a principal place of business at 2157 O’Toole Avenue, Suite H, San Jose, California.
Professional Service Agreement (for Use with Manufacturing Services Only)Professional Services Agreement • March 31st, 2005 • Hemosense Inc • New York
*** Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted portions have been filed separately with the Commission.
HEMOSENSE, INC. NON-EXCLUSIVE SALES REPRESENTATIVE AND SERVICES AGREEMENTNon-Exclusive Sales Representative and Services Agreement • March 31st, 2005 • Hemosense Inc • California
This Non-Exclusive Sales Representative and Services Agreement (this “Agreement”) takes effect November 12, 2002 (“Effective Date”), between HemoSense, Inc. (“HemoSense”), a Delaware corporation with principal offices at 600 Valley Way, Milpitas, CA 95035, USA, and Innovative Medical Product Consultants, GmbH (“Representative”), a business organized and existing under the laws of Germany with principle offices at Max-Planck-Strasse 22, 50858 Cologne, Germany.
SETTLEMENT AGREEMENT AND MUTUAL RELEASESettlement Agreement • March 31st, 2005 • Hemosense Inc • Massachusetts
This Settlement Agreement and Mutual Release (the “Settlement Agreement”) is made and entered into as of the 16th day of July, 2004, by and between Inverness Medical Switzerland GmbH (“Inverness”), a corporation organized and existing under the laws of Switzerland with offices located at Bundesplat 10, 6300 Zug, Switzerland, and HemoSense, Inc. (“HemoSense”), a Delaware corporation with offices located at 651 River Oaks Parkway, San Jose, California 95134, United States of America (collectively the “Parties”)
HEMOSENSE, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • March 31st, 2005 • Hemosense Inc • Delaware
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of February 7, 2005, among HemoSense, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A-2 Preferred Stock (the “Series A-2 Investors”) listed on Exhibit A hereto, the holders of the Company’s Series B-2 Preferred Stock (the “Series B-2 Investors”) listed on Exhibit B hereto, the holders of the Company’s Series C-2 Preferred Stock (the “Series C-2 Investors”) listed on Exhibit C hereto, and the purchasers of the Company’s Series C-3 Preferred Stock listed on Exhibit D hereto, including each “Additional Purchaser” as defined in the Series C-3 Preferred Stock Purchase Agreement, of even date herewith, who has executed a counterpart signature page hereto which sets forth such Additional Purchaser’s name and address (the “Series C-3 Investors” and collectively with the Series A-2 Investors, the Series B-2 Investors and the Series C-2 Investors, the “Investors”) and their trans
DISTRIBUTION AGREEMENTDistribution Agreement • March 31st, 2005 • Hemosense Inc
This AGREEMENT made as of June 30, 2004 (the “EFFECTIVE DATE”) by and between HEMOSENSE, Inc., (hereafter referred to as “HEMOSENSE”), a California Corporation, and Medline Industries, Inc., an Illinois Corporation with offices at One Medline Place, Mundelein, IL 60060 (hereafter referred to as “MEDLINE”). Each of HEMOSENSE and MEDLINE are referred to in this Agreement as a “PARTY” and collectively as the “PARTIES.”
PHYSICIANPLUS™ AGREEMENT (Branded Products)Physicianplus Agreement • March 31st, 2005 • Hemosense Inc • Illinois
This PHYSICIAN PLUS AGREEMENT (“Agreement”), effective August 15, 2004 (“Effective Date”), is between Hemosense, Inc., a California corporation with its principal offices located at 651 River Oaks Parkway, San Jose, California 95134, hereinafter called “SUPPLIER,” and Cardinal Health 200, Inc., a Delaware Corporation that is the Medical Products and Services Group of Cardinal Health, with offices located at 1450 Waukegan Road, McGaw Park, Illinois 60085, hereinafter called “DISTRIBUTOR.”
CONSULTING AGREEMENTConsulting Agreement • March 31st, 2005 • Hemosense Inc • California
This agreement (“Agreement”) is dated May 17, 2002 (“Effective Date”) and is by and between HemoSense, Inc., a Delaware corporation having a place of business at 600 Valley Way Milpitas, CA, 95035 USA (“Company”) and Innovative Medical Product Consultants, GmbH, a business organized and existing under the laws of Germany and having a place of business at Bonnerstrasse 528, 50968 Cologne, Germany (referred to herein as either “Consultant” or “IMedPro”).
HEMOSENSE INR PST SUPPLIER AGREEMENTSupplier Agreement • March 31st, 2005 • Hemosense Inc • New York
This AGREEMENT made as of April 2, 2004 by and between Raytel Cardiac Services, with its principal place of business, 7 Waterside Crossing, Windsor, CT 06095 (hereafter referred to as “RCS” or “DISTRIBUTOR”), and HemoSense, Inc., with its principal place of business 600 Valley Way, Milpitas, CA 95035 (hereafter referred to as “HemoSense” or “SUPPLIER”), a California Corporation, and referred to collectively hereafter as “the PARTIES”.
MANUFACTURE AND SUPPLY AGREEMENTManufacturing Agreement • March 31st, 2005 • Hemosense Inc • California
This MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”) is made and entered into as March 7, 2005 (“Effective Date”), by and between HemoSense, Inc., having an office at 651 River Oaks Parkway, San Jose, CA 95134 (“HemoSense”), and Haematologic Technologies, Inc., having an office at 57 River Road, Unit 1021, Essex Junction, VT 05452 (“HTI”). (Each of HemoSense and HTI are a “Party”; collectively the “Parties.”)
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 31st, 2005 • Hemosense Inc • California
THIS LOAN AND SECURITY AGREEMENT NO. 3821 (this “Agreement”) is entered into as of March 5, 2004, by and between LIGHTHOUSE CAPITAL PARTNERS V, L.P. (“Lender”) and HEMOSENSE, INC., a Delaware corporation (“Borrower”).
HEMOSENSE, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2005 • Hemosense Inc • California
This Agreement is entered into as of June 3, 2002, (the “Effective Date”) by and between HemoSense, Inc. (the ”Company”), and James D. Merselis (“Executive”).
DISTRIBUTION AGREEMENT between HemoSense, IncDistribution Agreement • March 31st, 2005 • Hemosense Inc
The two parties have agreed to interpret this agreement in a positive sense for the benefit of both of them and to cooperate in a spirit of partnership
AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • March 31st, 2005 • Hemosense Inc
This AGREEMENT is made as of March 1st 2005 (the “Effective Date”), by and between HemoSense, Inc., (hereafter referred to as “HemoSense”), a California Corporation, and Quality Assured Services, Inc. (aka, QAS), with its principal place of business 1506 N Orange Blossom Trail, Orlando, Florida, 32804 (hereafter referred to as “Distributor”). As used in this Agreement, HemoSense and Distributor are each referred to as a “Party” and collectively as “the Parties.” This Agreement amends, supercedes and restates in its entirety the Distribution Agreement by and between the Parties dated March 31, 2003 (the “Original Agreement”).
